Countries could ignore patents for coronavirus treatments, vaccines if unavailable internationally

While the leaders of several countries have called for a global, egalitarian approach to distributing a potential coronavirus vaccine or treatment, there's some concern that certain governments, including those in Washington, Beijing, and New Delhi, are intent on prioritizing domestic use, NBC News reports.

The U.S. Health and Human Services Department expressed such a sentiment in a March statement, while an op-ed in China's state-run newspaper The Global Times said "China has to be by itself in this crucial field." Billionaire Cyrus Poonawalla, the owner of the Serum Institute of India — the world's largest vaccine producer by volume — has said the majority of a coronavirus vaccine "would have to go to our countrymen before it goes abroad."

There's probably not a lot other countries can do about it, per NBC News. But Søren Holm, a professor of bioethics at the University of Manchester, said governments might be willing to take some desperate measures to produce treatments or a vaccine if the country is on the brink of collapse. One possibility is ignoring patents covering drugs and to begin manufacturing them without consent. South Africa made that choice with HIV/AIDS medicine in the 1990s, and drug companies eventually licensed the medication at a lower price. "It showed that these type of threats tend to work," Holm said. Read more at NBC News.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up